G6PD and non-autoimmune hemolytic anemia: Primaquine administration is associated with toxicity manifested as haemolytic anaemia and is contraindicated for individuals deficient of the glucose-6-phosphate dehydrogenase (G6PD) enzyme or pregnant women [10–12].